Timber pharmaceuticals announces presentation at 2021 h.c. wainwright global life sciences conference

Woodcliff lake, n.j., march 05, 2021 (globe newswire) -- via newmediawire -- timber pharmaceuticals, inc. ("timber" or the “company”) (nyse american: tmbr), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that timber's chief executive officer john koconis will present a corporate overview at the virtual 2021 h.c. wainwright global life sciences conference being held on march 9-10, 2021.
TMBR Ratings Summary
TMBR Quant Ranking